Nancy C. Andrews
Director, Charles River Laboratories.
Companies
- Maze Therapeutics, Inc.Board member Jan 30, 2025 to now1
- Charles River LaboratoriesBoard member Mar 4, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Recent filings
- Aug 18, 2026Sold 573 shares at $285.24 of CIK 11006823
- Aug 18, 2026Exercised options 573 shares at $164.30 of CIK 11006823
- May 12, 2026Gift 3,964 shares of CIK 11006824
- May 12, 2026Gift 3,964 shares of CIK 11006824
- May 8, 2026Granted 1,438 shares at $177.62 of CIK 11006825
- May 21, 2025Granted 946 shares at $134.98 of CIK 11006826
- May 13, 2024Granted 559 shares at $228.41 of CIK 11006827
- May 15, 2023Granted 664 shares of CIK 11006828
- May 11, 2022Granted 575 shares of CIK 11006829
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Aug 20, 2026
- 4SEC EDGARForm 4 filed May 14, 2026
- 5SEC EDGARForm 4 filed May 11, 2026
- 6SEC EDGARForm 4 filed May 23, 2025
- 7SEC EDGARForm 4 filed May 15, 2024
- 8SEC EDGARForm 4 filed May 17, 2023
- 9SEC EDGARForm 4 filed May 13, 2022